Angiotensin enzyme inhibitors contractile function stunned myocardium different mechanisms action Angiotensin enzyme ACE inhibitors contractile function myocardium brief episode coronary artery occlusion mechanism action unresolved addition possible hemodynamic effects ACE inhibitors synthesis cardioprotective prostaglandins beneficial effects ACE inhibitors sulfhydryl group due part ability thiol compounds nonspecific antioxidants direct scavengers cytotoxic oxygen-derived free radicals question effects sulfhydryl-containing ACE inhibitor zofenopril sulfhydryl-containing stereoisomer captopril SQ ACE inhibitor properties nonsulfhydryl-containing ACE inhibitor enalaprilat solvent time reperfusion recovery contractile function minutes coronary occlusion anesthetized open-chest dog Segment control animals depressed reperfusion baseline preocclusion values hours reperfusion contrast treatment agents postischemic dysfunction segment shortening baseline values hours reflow dogs SQ enalaprilat vs control value improvements segment result altered oxygen supply demand reperfusion inasmuch significant differences systemic hemodynamic parameters myocardial blood flow groups second phase study improved contractile function enalaprilat treatment infusion potent cyclooxygenase inhibitor indomethacin segment shortening hours treatment/reperfusion hours indomethacin infusion vs hours reperfusion Infusion indomethacin effect contractile function zofenopril treatment sulfhydryl- versus nonsulfhydryl-containing agents contractile function stunned myocardium different mechanisms action enalaprilat attenuates postischemic dysfunction part prostaglandin-mediated mechanism salutary effects zofenopril SQ due part antioxidant properties sulfhydryl moiety 